These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7730477)

  • 1. Avidity of specific IgG antibodies elicited by immunisation against Haemophilus influenzae type b.
    Agbarakwe AE; Griffiths H; Begg N; Chapel HM
    J Clin Pathol; 1995 Mar; 48(3):206-9. PubMed ID: 7730477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Avidity and bactericidal activity of antibody elicited by different Haemophilus influenzae type b conjugate vaccines. The Vaccine Study Group.
    Schlesinger Y; Granoff DM
    JAMA; 1992 Mar; 267(11):1489-94. PubMed ID: 1538539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of carrier protein priming on antibody responses to Haemophilus influenzae type b conjugate vaccines in infants.
    Granoff DM; Holmes SJ; Belshe RB; Osterholm MT; McHugh JE; Anderson EL
    JAMA; 1994 Oct; 272(14):1116-21. PubMed ID: 7933324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity of Haemophilus influenzae type b conjugate vaccines in infant rhesus monkeys.
    Vella PP; Ellis RW
    Pediatr Res; 1991 Jan; 29(1):10-3. PubMed ID: 2000253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety, tolerability, and immunogenicity of concurrent administration of Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) with either measles-mumps-rubella vaccine or diphtheria-tetanus-pertussis and oral poliovirus vaccines in 14- to 23-month-old infants.
    Dashefsky B; Wald E; Guerra N; Byers C
    Pediatrics; 1990 Apr; 85(4 Pt 2):682-9. PubMed ID: 2107519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pattern of functional antibody activity against Haemophilus influenzae type B (Hib) in infants immunized with diphtheria-tetanus-pertussis/Hib Brazilian combination vaccine.
    Matos DC; Silva AM; Neves PC; Martins RM; Homma A; Marcovistz R
    Braz J Med Biol Res; 2009 Dec; 42(12):1242-7. PubMed ID: 19893995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interchangeability of conjugated Haemophilus influenzae type b vaccines in infants.
    Anderson EL; Decker MD; Englund JA; Edwards KM; Anderson P; McInnes P; Belshe RB
    JAMA; 1995 Mar; 273(11):849-53. PubMed ID: 7869554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of naturally acquired and vaccine-induced antibodies to Haemophilus influenzae type b capsular polysaccharide.
    Jelonek MT; Chang SJ; Chiu CY; Park MK; Nahm MH; Ward JI
    Infect Immun; 1993 Dec; 61(12):5345-50. PubMed ID: 8225608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional differences in idiotypically defined IgG1 anti-polysaccharide antibodies elicited by vaccination with Haemophilus influenzae type B polysaccharide-protein conjugates.
    Lucas AH; Granoff DM
    J Immunol; 1995 Apr; 154(8):4195-202. PubMed ID: 7706754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of immunologic memory in infants primed with Haemophilus influenzae type b conjugate vaccines.
    Granoff DM; Holmes SJ; Osterholm MT; McHugh JE; Lucas AH; Anderson EL; Belshe RB; Jacobs JL; Medley F; Murphy TV
    J Infect Dis; 1993 Sep; 168(3):663-71. PubMed ID: 8354908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and immunogenicity of haemophilus influenzae type B polysaccharide or conjugate vaccines in an elderly adult population.
    Lottenbach KR; Granoff DM; Barenkamp SJ; Powers DC; Kennedy D; Irby-Moore S; Homan SM; Mink CM
    J Am Geriatr Soc; 2004 Nov; 52(11):1883-7. PubMed ID: 15507066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An enzyme-linked immunosorbent assay for quantitation of Haemophilus Influenzae type b polysaccharide-specific IgG1 and IgG2 in human and infant rhesus monkey sera.
    Dolan KT; Staub JM; Schofield TL; Ahonkhai VI; Ellis RW; Vella PP
    J Immunoassay; 1991; 12(4):543-64. PubMed ID: 1806588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional antibody activity elicited by fractional doses of Haemophilus influenzae type b conjugate vaccine (polyribosylribitol phosphate-tetanus toxoid conjugate).
    Romero-Steiner S; Fernandez J; Biltoft C; Wohl ME; Sanchez J; Feris J; Balter S; Levine OS; Carlone GM
    Clin Diagn Lab Immunol; 2001 Nov; 8(6):1115-9. PubMed ID: 11687449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Avidity maturation of antibody to Haemophilus influenzae type b (Hib) after immunization with diphtheria-tetanus-acellular pertussis-hib-hepatitis B combined vaccine in infants.
    Pichichero ME; Voloshen T; Zajac D; Passador S
    J Infect Dis; 1999 Oct; 180(4):1390-3. PubMed ID: 10479180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-polyribosyl-ribitol phosphate and anti-N. meningitidis outer membrane protein antibody levels following PRP-OMP conjugate vaccination.
    Wong VK; Kim KS
    Vaccine; 1993; 11(9):979-80. PubMed ID: 8212847
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunologic priming by one dose of Haemophilus influenzae type b conjugate vaccine in infancy.
    Kurikka S; Käyhty H; Saarinen L; Rönnberg PR; Eskola J; Mäkelä PH
    J Infect Dis; 1995 Nov; 172(5):1268-72. PubMed ID: 7594663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody affinity in infants after immunization with conjugated capsular polysaccharide from Haemophilus influenzae type b.
    Hetherington SV; Rutkowski AF
    J Infect Dis; 1990 Nov; 162(5):1185-8. PubMed ID: 2230242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized trial to assess immunogenicity and safety of Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine in infants.
    Marchant CD; Miller JM; Marshall GS; Blatter M; Aris E; Friedland LR; Boutriau D;
    Pediatr Infect Dis J; 2010 Jan; 29(1):48-52. PubMed ID: 20035207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated levels of maternal anti-tetanus toxin antibodies do not suppress the immune response to a Haemophilus influenzae type b polyribosylphosphate-tetanus toxoid conjugate vaccine.
    Panpitpat C; Thisyakorn U; Chotpitayasunondh T; Fürer E; Que JU; Hasler T; Cryz SJ
    Bull World Health Organ; 2000; 78(3):364-71. PubMed ID: 10812736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and immunogenicity of PRP-T combined with DTP: excretion of capsular polysaccharide and antibody response in the immediate post-vaccination period.
    Miller MA; Meschievitz CK; Ballanco GA; Daum RS
    Pediatrics; 1995 Apr; 95(4):522-7. PubMed ID: 7700752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.